Article citationsMore>>

Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., et al. (2006) Regulatory CD56 (Bright) Natural Killer Cells Mediate Immunomodulatory Effects of IL-2R Alpha-Targeted Therapy (Daclizumab) in Multiple Sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 103, 5941-5946.
http://dx.doi.org/10.1073/pnas.0601335103

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top